ArticleFrontiers in immunology2024

Case report: Sintilimab combined with anlotinib as neoadjuvant chemotherapy for metastatic bone tumor resection in patients with PSC.

Zheming Bao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.